centrifuged at 2000 rpm x 10 min. Tested concentrations, incubations, sample collection times and inoculations onto SDA plates were the same as described for TK assay. PAFE was calculated according to the equation PAFE= T -C (T: time required to increase by 1 log the counts in treated culture; C: time required to increase by 1 log the counts following the last washing) [15] .
Fungicidal activity was defined as a growth reduction ≥ 3 log (99.9%), and fungistatic activity, as a reduction < 3 log (< 99.9%) in CFU from the starting inoculum. The ratios of the log killing during PAFE assays to the log killing during TK assays were also calculated [16] .
Statistical analysis. The differences in PAFEs among the anidulafungin different concentrations and species were evaluated by ANOVA (GraphPad Software, USA). A P value < 0.05 was considered significant.
INTRODUCTION
Invasive candidiasis is a significant cause of morbidity and mortality, especially among patients suffering from severe immunodeficiency. Although Candida albicans remains the most common aetiology, the incidence of candidiasis due to non-C. albicans species is increasing. Most Candida bloodstream infections are caused by C. albicans, Candida parapsilosis, Candida glabrata, Candida tropicalis, and Candida krusei [1, 2] . Moreover, C. albicans and C. parapsilosis have close-related species, such as Candida dubliniensis and Candida africana (C. albicans related species) or Candida orthopsilosis and Candida metapsilosis (C. parapsilosis complex). Differences and variability in the prevalence and antifungal susceptibility of these species have been reported [3, 4] .
Postantifungal effect (PAFE) describes how long an antifungal drug continues acting after it has been removed. This effect depends on both the fungal species and antifungal drug, and it may be relevant for antifungal therapy, having clinical relevance for establishing dosage schedules. Echinocandins and amphotericin B (fungicidal drugs) exert prolonged PAFE against C. albicans while triazoles (fungistatic drugs) possess shorter PAFE. Theoretically, antifungal drugs with long PAFE will require less frequent administration than those with shorter PAFEs [5, 6] . The aim of this study has been to evaluate the PAFE of clinically relevant concentrations of anidulafungin against C. albicans and C. parapsilosis related species.
MATERIAL AND METHODS
Microorganisms. Twenty-one Candida clinical isolates and culture collection strains were studied (table 1) . The clinical isolates were identified as previously described [7, 8] .
In vitro susceptibility testing. Anidulafungin (Pfizer SLU, Spain) was dissolved in dimethyl sulfoxide. Further dilutions were done in standard RPMI 1640 medium (Sigma-Aldrich, Spain). Minimum concentrations that produce ≥ 50% growth reductions (MICs) after 24 h of incubation were determined according to the M27-A3, M27-S4 and M60 documents [9, 10] .
Time-kill procedures. Time-kill studies (TK) were performed out in microtiter plates in a computer-controlled microbiological incubator (BioScreen C MBR, LabSystems, Finland) in RPMI (200 µl) using an inoculum of 1-5 x 10 5 cells/ml, as previously described [11] . The concentrations assayed were 0.125, 0.5 and 2 mg/L for C. albicans related species, and 0.25, 2 and 8 mg/L for C. parapsilosis complex. Aliquots were removed from each well at 0, 2, 4, 6, 24 and 48 h, after dilution in phosphate buffered saline (PBS), the samples were inoculated onto Sabouraud dextrose agar (SDA) plates. Colonies were counted after incubation of the plates (36 ± 1 ˚C) for 48 h. All experiments were performed in duplicate. The limit of quantification was 20 colony forming units (CFU).
Postantifungal effect. PAFE was evaluated as previously described [12] [13] [14] . After an incubation period of 1 h, anidulafungin was removed by serial washing in PBS and (table 2) . A significant and prolonged PAFE (≥ 42 h) against 6 out of 7 (86%) strains of C. parapsilosis complex was observed with 8 mg/L of anidulafungin (P < 0.05) (table 3), but fungicidal endpoint was achieved only against C. metapsilosis UPV/EHU 07-045. This concentration was fungicidal against 6 out 7 (86%) strains from the C. parapsilosis complex and fungistatic against 1 C. orthopsilosis, in TK experiments. The mean value of PAFE/TK ratio was 15.48 (8 mg/L) for C. parapsilosis complex. There were no significant differences between the PAFE of anidulafungin against C. parapsilosis, C. metapsilosis and C. orthopsilosis (table  3) .
Mean anidulafungin PAFE against C. albicans related species (39.6 ± 26.81 h) (2 mg/L) did not differ from that one against C. parapsilosis complex (37.6 ± 14.32 h) (8 mg/L) ( figure 1 and 2 ). Candida but does not achieve this effect against all isolates. This effect depends on isolate, species, antifungal concentration and test conditions [5, 11, 19] . Similarly, Clancy et al. reported prolonged PAFE of caspofungin against C. albicans, C. parapsilosis and C. glabrata, but fungicidal activity was not observed in TK or PAFE experiments [16] . For this reason, it would be advisable to perform in vitro susceptibly testing, such as TK and PAFE studies, since killing curves are tools that provide much information about the antifungal activity.
DISCUSSION
Smith et al. [15] described fungicidal activity of anidulafungin in TK and in PAFE against C. glabrata and C. parapsilosis at similar concentrations. Moreover, Nguyen et al. [12] evaluated the anidulafungin PAFE against several Candida species, reporting fungicidal PAFE against the former species. However, we only observed fungicidal activity against C. parapsilosis in TK experiments, except for one strain of C. metapsilosis with fungicidal PAFE.
In the current study, there were not significant differences in anidulafungin activity among the species related to C. albicans and C. parapsilosis. However, we have observed previously statistically significant differences between species related to against C. albicans and C. parapsilosis in the duration of micafungin and caspofungin PAFEs, which were longer against C. albicans related species than against C. parapsilosis complex [13, 14] . Anidulafungin is the echinocandin with greater PAFE against C. parapsilosis. Conversely, micafungin was the echinocandin that displayed the lowest PAFE against the C. parapsilosis complex. However, all echinocandins showed a similar PAFE against the C. albicans related species, with a slightly but non-significant higher PAFE with micafungin [13, 14] . In PAFE experiments anidulafungin (≤ 2 mg/L) and micafungin (2 mg/L) achieved the fungicidal endpoint against 2 out 14 (14%) strains of C. albicans related species (C. albicans UPV/EHU 99-101, C. dubliniensis UPV/ EHU 00-135 and C. albicans UPV/EHU 99-102, and C. dubliniensis UPV/EHU 00-135, respectively). Caspofungin (2 mg/L) only achieved this endpoint against 1 out of 14 (7%) strains (C. albicans UPV/EHU 99-101). Only anidulafungin (8 mg/L) displayed a fungicidal PAFE against the C. parapsilosis complex (1 out 7, 14% strains, C. metapsilosis UPV/EHU 07-045) [13, 14] . Fungal growth characteristics or binding affinities of each drug could be possible explanations for PAFE differences [12] . PAFE may have clinical relevance to the design of dosing regimens for antifungal agents, as those antifungal drugs with longer PAFEs may be administered less frequently than those ones with shorter PAFEs [5, 20] .
In conclusion, anidulafungin showed a significant and ical agents of invasive candidiasis, being in some institutions more prevalent than C. krusei [17] . To our knowledge, this is the first study that shows and compares the PAFE of anidulafungin against the emerging species C. dubliniensis, C. africana, C. metapsilosis and C. orthopsilosis. PAFE and TK experiments of anidulafungin against C. albicans and C. parapsilosis have not been widely evaluated and most studies included low numbers of isolates [5, 12, 15] . Moreover, this study provides a comparison among the in vitro activities of anidulafungin, caspofungin and micafungin [13, 14] .
Anidulafungin MICs were consistent with those reported in previous studies [8, 18] . In the current study, anidulafungin exerted good fungicidal activity against most strains of C. parapsilosis complex but this activity was lower against C. albicans related species (with 8 mg/L and 2 mg/L, respectively). This discrepancy in the activity of the echinocandins against different species of Candida has been reported previously [11, 12, 16, 19] ; anidulafungin is considered fungicide against AND, anidulafungin; TK, time-kill; PAFE, postantifungal effect. 
